Artelo Biosciences (ARTL) Research & Development (2017 - 2025)
Artelo Biosciences (ARTL) reported Research & Development of $893,000 for Q4 2025, down 63.9% from $2.48 million a year earlier and down 30.0% from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Research & Development (2017 - 2025) Analysis & Trends
For FY2025, Artelo Biosciences posted Research & Development of $5.42 million, down 9.5% from FY2024.
- Research & Development has a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
- By year, Research & Development came in at $5.99 million in FY2024 (+5.2%), $5.7 million in FY2023 (+31.7%), $4.32 million in FY2022 (+14.3%) and $3.78 million in FY2021.
- The Q4 2025 figure ranks as the lowest quarterly Research & Development since Q3 2024.
- Year over year, Research & Development gained in five of the last eight quarters, with growth averaging 39.3%.
- The high point for year-over-year Research & Development in five years was Q3 2025 (growth of 292.3%); the low point was Q3 2024 (a decline of 79.5%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $1.28 million (Q3 2025), $1.87 million (Q2 2025) and $1.38 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Artelo Biosciences | 85,673.20 | -5.05 Mn | - | 893,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 893,000.00 |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 2.48 Mn |
| Sep 30, 2024 | 325,000.00 |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 2.12 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 752,000.00 |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 464,000.00 |
| Nov 30, 2021 | 1.27 Mn |
| May 31, 2021 | 951,204.00 |
| Feb 28, 2021 | 663,359.00 |
| Nov 30, 2020 | 595,000.00 |
API Access
Artelo Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();